Empagliflozin on top of metformin treatment improves arterial function in patients with type 1 diabetes mellitus

Empagliflozin on top of metformin treatment improves arterial function in patients with type 1 diabetes mellitus

Abstract Background Deteriorated arterial function and high incidence of cardiovascular events characterise diabetes mellitus. Metformin and recent antidiabetic drugs, SGLT2 inhibitors, reduce cardiovascular events. We explored the possible effects of empagliflozin’s effect on top of metformin treat...

Full description

Bibliographic Details
Main Authors: Mojca Lunder, Miodrag Janić, Miha Japelj, Andrej Juretič, Andrej Janež, Mišo Šabovič
Format: Article
Language:English
Published: BMC 2018-12-01
Series:Cardiovascular Diabetology
Subjects:
Empagliflozin
Metformin
Empagliflozin/metformin
Vascular protection
Arterial stiffness
Endothelial function
Online Access:http://link.springer.com/article/10.1186/s12933-018-0797-6

Internet

http://link.springer.com/article/10.1186/s12933-018-0797-6

Similar Items